
zzso and intravenous zzso zzso antibiotics are the standard of care for all zzso zzso patients with zzso Recent work suggests that a low-risk population exists who might benefit from an alternate zzso 

A prospective zzso clinical trial was performed comparing oral zzso 750 zzso plus zzso 600 zzso every 8 hours with IV zzso 2 g plus zzso 600 zzso every 8 hours for the zzso zzso treatment of zzso episodes in low-risk zzso patients with zzso 

The oral regimen cured 35 of 40 episodes zzso response zzso whereas the IV regimen cured 41 of 43 episodes zzso response rate, P zzso zzso Although the cost of the oral regimen was significantly less than that of the IV regimen zzso zzso zzso it was associated with significant zzso toxicity zzso zzso zzso which led to early termination of the zzso Overall, combining its safety and zzso the IV regimen was superior zzso zzso zzso 

This prospective study suggested that zzso zzso therapy for zzso episodes in low-risk zzso patients with cancer is safe and zzso Better oral regimens are zzso 

